Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer.
about
Preservation of organ function in head and neck cancer.Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx.Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma.Hyper-fractionated Intensity Modulated Radiation Therapy (HF-IMRT) in Head and Neck Cancer: The Technical Feasibility and Results of a Short Clinical Series.Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck.Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments.Effectiveness of CT assists for intraarterial chemotherapy: therapeutic outcome of chemoradiation for advanced head and neck cancer extending across the anatomical midline.Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis During Radiotherapy for Head and Neck Cancer.Pain management during radiotherapy and radiochemotherapy in oropharyngeal cancer patients: single-institution experience.Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
P2860
Q30459136-930E2F6C-71B4-4FF1-872A-2F81AAA5B88DQ34385645-FC431D4A-E962-4D47-A3C3-C5CB41FC4821Q35553791-4A91C2AC-6566-4321-9ED8-009FE19290DAQ35792578-550225D3-0B6A-4915-B45E-AA5A83056CFBQ35930366-30F46A87-17B1-4551-B8BA-0CE893F6DE9FQ37245384-EDDBA778-E162-49AC-AADE-7C8ADD1D3E9BQ37437083-1B7AD456-0A46-4AEE-8AD4-6271A52D87DDQ40233573-BC3E0B38-EC4B-496A-A7D5-4F969E99C604Q40449052-5724599E-AA76-4F86-BA8D-A3969AF4DBBCQ40547962-4E493A2C-F2AD-4F96-A7FC-C938C9F969DBQ46425931-9C806E44-9C39-4795-9ED8-0C7F8A3DC439Q49919540-188E7700-20E2-4769-ACAF-491427E198E7
P2860
Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase II trial of hyperfractio ...... and IVa head-and-neck cancer.
@ast
Phase II trial of hyperfractio ...... and IVa head-and-neck cancer.
@en
type
label
Phase II trial of hyperfractio ...... and IVa head-and-neck cancer.
@ast
Phase II trial of hyperfractio ...... and IVa head-and-neck cancer.
@en
prefLabel
Phase II trial of hyperfractio ...... and IVa head-and-neck cancer.
@ast
Phase II trial of hyperfractio ...... and IVa head-and-neck cancer.
@en
P2093
P2860
P1476
Phase II trial of hyperfractio ...... I and IVa head-and-neck cancer
@en
P2093
Charles Neal
Hoke Pollock
Joel Tepper
Kenneth Kotz
Marion Couch
Martin Meyerson
Michael Papagikos
Patrick D Maguire
Peter Ungaro
Sue Hamann
P2860
P304
P356
10.1016/J.IJROBP.2009.12.046
P407
P577
2010-04-08T00:00:00Z